Curaxis Pharmaceutical Corp.

CURAXIS’ MEMRYTE NAMED ONE OF THE TOP 100 DRUGS IN DEVELOPMENT TODAY BY R&D DIRECTIONS

Curaxis Pharmaceutical Corp. CEO Patrick S. Smith Comments on Recent Prana Research

Curaxis Pharmaceutical Corp.: STELLUNGNAHME VON CEO PATRICK S. SMITH VON CURAXIS PHARMACEUTICAL CORP. ZUM KÜRZLICH IN DER NEW YORK TIMES VERÖFFENTLICHTEN ARTIKEL ‘DRUG FIRMS FACE BILLIONS IN LOSSES IN ’11 AS PATENTS END’

Curaxis Pharmaceutical Corp.: CEO PATRICK S. SMITH COMMENTS ON RECENT NEW YORK TIMES ARTICLE

Curaxis Pharmaceutical Management auf Roadshow in Europa fuer Access Capital & Pursue Strategic Partners

Curaxis Pharmaceutical Management auf Roadshow in Europa für Access Capital & Pursue Strategic Partners

Curaxis Pharmaceutical Management on Roadshow in Europe to Access Capital & Pursue Strategic Partners

Curaxis Pharmaceutical Management on Roadshow in Europe to Access Capital & Pursue Strategic Partners